Capitol Health Limited (CAJ.AX)
AUD 0.39
(0.0%)
AUD 0.39
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 23.4 Million AUD | 17.98% |
| 2023 | 19.84 Million AUD | -2.27% |
| 2022 | 41.12 Million AUD | -14.36% |
| 2021 | 44.22 Million AUD | 32.08% |
| 2020 | 31.9 Million AUD | 59.46% |
| 2019 | 22.8 Million AUD | 5.81% |
| 2018 | 3.1 Million AUD | 144.45% |
| 2017 | 8.81 Million AUD | -24.41% |
| 2016 | 11.66 Million AUD | -45.05% |
| 2015 | 21.22 Million AUD | 51.05% |
| 2014 | 14.04 Million AUD | 74.55% |
| 2013 | 7.95 Million AUD | 47.61% |
| 2012 | 5.64 Million AUD | 33.99% |
| 2011 | 3.9 Million AUD | 56.46% |
| 2010 | 2.6 Million AUD | 19.38% |
| 2009 | 182.55 Thousand AUD | 119.66% |
| 2008 | 991.86 Thousand AUD | 257.11% |
| 2007 | -881.3 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | 18.76 Million AUD | 0.0% |
| 2024 FY | - AUD | 22.62% |
| 2024 Q2 | 23.95 Million AUD | 0.0% |
| 2023 FY | - AUD | -2.27% |
| 2023 Q2 | 19.72 Million AUD | 0.0% |
| 2023 Q4 | 20.46 Million AUD | 0.0% |
| 2022 Q2 | 22.19 Million AUD | 0.0% |
| 2022 FY | - AUD | -14.36% |
| 2022 Q4 | 18.92 Million AUD | 0.0% |
| 2021 Q2 | 26.55 Million AUD | 0.0% |
| 2021 FY | - AUD | 32.08% |
| 2021 Q4 | 21.46 Million AUD | 0.0% |
| 2020 FY | - AUD | 59.46% |
| 2020 Q2 | 17.69 Million AUD | 0.0% |
| 2020 Q4 | 18.66 Million AUD | 0.0% |
| 2019 FY | - AUD | 5.81% |
| 2019 Q4 | 14.58 Million AUD | 0.0% |
| 2019 Q2 | 11.85 Million AUD | 0.0% |
| 2018 FY | - AUD | 144.45% |
| 2018 Q2 | 9.09 Million AUD | 0.0% |
| 2017 Q2 | 3.76 Million AUD | 0.0% |
| 2017 FY | - AUD | -24.41% |
| 2016 FY | - AUD | -45.05% |
| 2016 Q2 | 10.59 Million AUD | 0.0% |
| 2015 Q4 | 12.33 Million AUD | 0.0% |
| 2015 Q2 | 8.88 Million AUD | 0.0% |
| 2015 FY | - AUD | 51.05% |
| 2014 Q2 | 6.35 Million AUD | 0.0% |
| 2014 FY | - AUD | 74.55% |
| 2014 Q4 | 7.69 Million AUD | 0.0% |
| 2013 Q2 | 3.18 Million AUD | 0.0% |
| 2013 FY | - AUD | 47.61% |
| 2013 Q4 | 4.86 Million AUD | 0.0% |
| 2012 Q1 | 975.11 Thousand AUD | 0.0% |
| 2012 Q3 | 1.41 Million AUD | 0.0% |
| 2012 Q4 | 1.41 Million AUD | 0.0% |
| 2012 Q2 | 1.41 Million AUD | 44.77% |
| 2012 FY | - AUD | 33.99% |
| 2011 Q4 | 975.11 Thousand AUD | 0.0% |
| 2011 Q1 | 650.26 Thousand AUD | 0.0% |
| 2011 Q2 | 975.11 Thousand AUD | 49.96% |
| 2011 Q3 | 975.11 Thousand AUD | 0.0% |
| 2011 FY | - AUD | 56.46% |
| 2010 Q2 | 650.26 Thousand AUD | 436.05% |
| 2010 Q3 | 650.26 Thousand AUD | 0.0% |
| 2010 Q1 | 121.3 Thousand AUD | 0.0% |
| 2010 FY | - AUD | 19.38% |
| 2010 Q4 | 650.26 Thousand AUD | 0.0% |
| 2009 Q2 | 121.3 Thousand AUD | -54.19% |
| 2009 FY | - AUD | 119.66% |
| 2009 Q4 | 121.3 Thousand AUD | 0.0% |
| 2009 Q3 | 121.3 Thousand AUD | 0.0% |
| 2009 Q1 | 264.77 Thousand AUD | 0.0% |
| 2008 Q1 | -220.32 Thousand AUD | 0.0% |
| 2008 Q4 | 264.77 Thousand AUD | 0.0% |
| 2008 FY | - AUD | 257.11% |
| 2008 Q3 | 264.77 Thousand AUD | 0.0% |
| 2008 Q2 | 264.77 Thousand AUD | 220.17% |
| 2007 Q3 | -220.32 Thousand AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2007 Q2 | -220.32 Thousand AUD | 0.0% |
| 2007 Q4 | -220.32 Thousand AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Pacific Smiles Group Limited | 45.21 Million AUD | 48.226% |
| Regis Healthcare Limited | 191.44 Million AUD | 87.773% |
| Ramsay Health Care Limited | 2.08 Billion AUD | 98.878% |